鹰瞳科技受邀参加首届全球眼科大会，并获2025全球眼科用户体验奖

Core Insights - The first Global Ophthalmology Conference was held in Zhongguancun, showcasing advancements in ophthalmic technology and awarding the 2025 Global Ophthalmology User Experience Award to Airdoc [1][3] - The conference released the 2025 Global Ophthalmology Innovation Annual White Paper and provided policy guidance for the high-quality development of innovative medicine in Beijing [3][10] - Airdoc's CEO presented the application of the "Wanyu Model" in various medical scenarios, emphasizing the importance of real-world validation for data-driven medical AI [5][6] Group 1: Conference Highlights - The conference featured awards such as the Global Ophthalmology Innovation Award and International Cooperation Award, recognizing contributions from members of the Zhongguancun Alliance [3] - Policy measures supporting innovative medicine in Beijing and Haidian District were discussed, promoting the deployment of innovative products in local hospitals [3][10] - Eight projects, including those from Airdoc, were successfully deployed in 2024, indicating a proactive approach to innovation in healthcare [3] Group 2: Airdoc's Innovations - Airdoc has developed an AI-integrated solution for retinal imaging, enabling automatic capture of fundus images and risk identification for cardiovascular diseases [6] - The company aims to address the imbalance in medical resources and enhance diagnostic capabilities in primary healthcare institutions [6] - Airdoc's commitment to making quality healthcare accessible to all is reflected in its ongoing efforts to leverage AI technology [10] Group 3: Industry Collaboration - The conference attracted experts, scholars, and representatives from various medical institutions, fostering discussions on the latest advancements in ophthalmic technology [10] - Local innovation companies, including Airdoc, showcased their latest technologies and products, facilitating opportunities for deep collaboration [8] - The event highlighted Haidian District's strengths and potential in the biomedicine sector, particularly in ophthalmic medical technology innovation [10]